Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Nagoya University Graduate School of Medicine, Nagoya (Japan)
4 More presentations in this session
Professor J. Januzzi (Boston, US)
Doctor N. del-Cuerpo-Salinas (Sant Joan d'Alacant, ES)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
